Epigral (EPIGRAL) | Financial Analysis & Statements
Epigral Ltd. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
6.1B
Gross Profit
2.9B
47.40%
Operating Income
1.2B
20.09%
Net Income
1.6B
26.49%
EPS (Diluted)
₹37.25
Balance Sheet Metrics
Total Assets
31.5B
Total Liabilities
12.5B
Shareholders Equity
19.0B
Debt to Equity
0.66
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Epigral Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 25.1B | 18.9B | 21.7B | 15.5B | 8.3B |
| Cost of Goods Sold | 14.1B | 11.2B | 11.7B | 8.0B | 4.1B |
| Gross Profit | 11.1B | 7.8B | 10.0B | 7.5B | 4.1B |
| Gross Margin % | 44.0% | 41.1% | 46.2% | 48.3% | 50.1% |
| Operating Expenses | |||||
| Research & Development | 5.5M | - | - | - | - |
| Selling, General & Administrative | 501.4M | 326.6M | 356.3M | 217.3M | 83.4M |
| Other Operating Expenses | 2.3B | 1.8B | 1.9B | 1.3B | 823.6M |
| Total Operating Expenses | 2.8B | 2.2B | 2.3B | 1.5B | 907.0M |
| Operating Income | 5.8B | 3.6B | 5.8B | 4.2B | 1.9B |
| Operating Margin % | 23.0% | 18.9% | 26.7% | 27.3% | 22.7% |
| Non-Operating Items | |||||
| Interest Income | 3.3M | 983.0K | 8.4M | 1.6M | 1.5M |
| Interest Expense | 425.2M | 623.3M | 497.9M | 319.1M | 309.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 5.4B | 2.9B | 5.2B | 3.8B | 1.6B |
| Income Tax | 1.8B | 948.8M | 1.7B | 1.3B | 600.2M |
| Effective Tax Rate % | 33.9% | 32.6% | 32.4% | 34.1% | 37.3% |
| Net Income | 3.6B | 2.0B | 3.5B | 2.5B | 1.0B |
| Net Margin % | 14.2% | 10.3% | 16.3% | 16.3% | 12.2% |
| Key Metrics | |||||
| EBITDA | 7.2B | 4.8B | 6.8B | 5.0B | 2.6B |
| EPS (Basic) | ₹84.68 | ₹47.14 | ₹85.03 | ₹60.84 | ₹24.27 |
| EPS (Diluted) | ₹84.68 | ₹47.14 | ₹85.03 | ₹60.84 | ₹17.26 |
| Basic Shares Outstanding | 42238943 | 41550158 | 41550158 | 41550158 | 41552665 |
| Diluted Shares Outstanding | 42238943 | 41550158 | 41550158 | 41550158 | 41552665 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Epigral Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 186.4M | 31.8M | 142.4M | 250.9M | 6.8M |
| Short-term Investments | 778.6M | 36.1M | 8.7M | 18.8M | - |
| Accounts Receivable | 2.3B | 1.8B | 1.7B | 2.6B | 1.2B |
| Inventory | 3.9B | 2.6B | 2.1B | 1.5B | 539.6M |
| Other Current Assets | 156.9M | 125.6M | 78.5M | 92.9M | - |
| Total Current Assets | 7.8B | 5.0B | 4.2B | 4.5B | 1.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 22.2B | 17.4B | 17.8B | 10.4B | 0 |
| Goodwill | 187.3M | 219.6M | 251.9M | 284.3M | 316.6M |
| Intangible Assets | 187.3M | 219.6M | 251.9M | 284.3M | 316.6M |
| Long-term Investments | 0 | 7.9M | 0 | 15.3M | 24.7M |
| Other Non-Current Assets | 301.2M | 1.0K | 162.3M | 100.0K | -1.0K |
| Total Non-Current Assets | 23.8B | 22.9B | 20.1B | 16.8B | 12.7B |
| Total Assets | 31.5B | 27.9B | 24.3B | 21.2B | 14.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.9B | 1.7B | 1.1B | 881.0M | 730.5M |
| Short-term Debt | 1.4B | 4.2B | 3.3B | 2.2B | 2.0B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 675.2M | 1.0K | 117.5M | 260.6M | -1.0K |
| Total Current Liabilities | 4.9B | 7.8B | 6.5B | 5.3B | 3.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.5B | 4.9B | 4.4B | 5.6B | 3.4B |
| Deferred Tax Liabilities | 2.9B | 2.1B | 1.7B | 917.5M | 308.1M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 7.6B | 7.6B | 7.2B | 8.7B | 3.8B |
| Total Liabilities | 12.5B | 15.4B | 13.6B | 14.0B | 7.6B |
| Equity | |||||
| Common Stock | 431.4M | 415.5M | 415.5M | 415.5M | 415.5M |
| Retained Earnings | 17.8B | 14.6B | 12.7B | 9.3B | 6.8B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 19.0B | 12.5B | 10.7B | 7.3B | 6.8B |
| Key Metrics | |||||
| Total Debt | 5.9B | 9.1B | 7.7B | 7.8B | 5.4B |
| Working Capital | 2.8B | -2.8B | -2.3B | -853.5M | -2.1B |
Balance Sheet Composition
Epigral Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 5.4B | 2.9B | 5.2B | 3.8B | 1.6B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.7B | -952.0M | 182.1M | -1.9B | -314.4M |
| Operating Cash Flow | 4.2B | 2.7B | 6.1B | 2.4B | 1.6B |
| Investing Activities | |||||
| Capital Expenditures | -1.9B | -4.0B | -4.2B | -4.6B | -2.0B |
| Acquisitions | - | 0 | -205.4M | 0 | 0 |
| Investment Purchases | -3.1B | 0 | -245.0K | 0 | -604.0K |
| Investment Sales | 2.3B | - | - | 13.8M | - |
| Investing Cash Flow | -2.6B | -4.0B | -4.4B | -4.5B | -2.0B |
| Financing Activities | |||||
| Share Repurchases | -950.0M | -550.0M | -609.2M | 0 | - |
| Dividends Paid | -418.6M | -251.2M | -242.2M | - | - |
| Debt Issuance | 1.4B | 2.1B | 747.5M | 3.6B | 407.0M |
| Debt Repayment | -2.5B | -2.0B | -1.4B | -1.2B | -872.0M |
| Financing Cash Flow | -869.1M | 658.6M | -1.4B | 2.4B | 88.1M |
| Free Cash Flow | 2.5B | -7.9M | 2.1B | -1.7B | 324.2M |
| Net Change in Cash | 682.7M | -664.0M | 295.3M | 315.0M | -298.0M |
Cash Flow Trend
Epigral Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.30
Forward P/E
14.90
Price to Book
2.46
Price to Sales
2.14
PEG Ratio
-0.24
Profitability Ratios
Profit Margin
13.97%
Operating Margin
10.05%
Return on Equity
18.78%
Return on Assets
11.35%
Financial Health
Current Ratio
1.31
Debt to Equity
25.57
Beta
-0.24
Per Share Data
EPS (TTM)
₹78.29
Book Value per Share
₹486.92
Revenue per Share
₹560.80
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EPIGRAL | 51.6B | 15.30 | 2.46 | 18.78% | 13.97% | 25.57 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Tata Chemicals | 176.6B | 108.83 | 0.79 | 1.04% | 1.23% | 32.13 |
| Deepak Fertilisers | 158.4B | 18.07 | 2.43 | 14.93% | 7.84% | 62.05 |
| Archean Chemical | 73.7B | 50.29 | 3.87 | 8.70% | 13.01% | 14.78 |
Financial data is updated regularly. All figures are in the company's reporting currency.





